Unraveling the immunologic vulnerabilities of diffuse hemispheric glioma, H3 G34-mutant.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.2082
Abstract: 2082 Background: Recent insights into the molecular basis of diffuse hemispheric glioma, H3 G34-mutant (DHG-G34), an incurable high-grade glioma, have opened new therapeutic possibilities. The oncohistone mutation in DHG-G34 impairs the epigenetic regulator SETD2, which… read more here.
Keywords: g34; diffuse hemispheric; hemispheric glioma; dhg g34 ... See more keywords